IDNA

Black Swan Sale

50% Off Elite

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	12.31%	Total Holdings	57	Perf Week	1.21%
Sponsor	Blackrock (iShares)	ETF Type		Tags	equity	Return% 3Y	-2.89%	AUM	125.14M	Perf Month	7.72%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-8.55%	NAV/sh		Perf Quarter	19.41%
Index	NYSE FactSet Global Genomics and Immuno...	Average Maturity		Tags	genomics	Return% 10Y		52W High	26.50 -0.28%	Perf Half Y	31.60%
Index Weighting		Commodity Type		Tags	pharmaceutical	Return% SI		52W Low	17.26 53.10%	Perf YTD	16.77%
Active/Passive		Quant Type		Tags	innovation	Flows% 1M	-3.98%	Volatility	2.32% 1.99%	Perf Year	14.25%
Dividend TTM	0.26 (1.00%)	ESG Type		Tags	-	Flows% 3M	-3.06%	ATR (14)	0.55	Perf 3Y	-6.56%
Dividend Ex-Date	Jun 16, 2025	Dividend Type		Sector/Theme		Flows% YTD	-10.66%	RSI (14)	63.40	Perf 5Y	-37.07%
Dividend Gr. 3/5Y	-10.34% 136.51%	Structure Type		Region		Flows% 1Y		Beta	0.97	Perf 10Y	-
Expense	0.47%	Growth/Value		SMA20	3.47%	Flows% 3Y		Rel Volume	0.55	Prev Close	25.83
Inverse/Leveraged		Market Cap		SMA50	7.52%	Flows% 5Y		Avg Volume	30.00K	Price	26.42
IPO	Jun 13, 2019	Option/Short	Yes / Yes	SMA200	19.73%	Trades		Volume	16,366	Change	2.30%

May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
04:33AM	Is Healthcare Losing the Status of Safe Haven? ETFs in Focus (Zacks)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
01:40PM	Loading…
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.42%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Sep-09-22 01:45PM	BlackRock Zeros in on Themed ETFs (ETF.com)
Mar-30-22 01:30PM	Vir Jumps 20% On S&P SmallCap 600 News (ETF.com)
Feb-25-22 09:59PM	Best Biotech ETFs for Q2 2022 (Investopedia)
Dec-06-21 10:15AM	BlackRock Releases Megatrends Report (ETF.com)
10:15AM	Loading…
Oct-21-21 10:15AM	ETF Battles: ARKG Vs IDNA Vs GNOM (ETF.com)
May-18-20 03:42PM	Biotech ETFs to watch as companies push for coronavirus treatments (Yahoo Finance Video) +5.27%
10:51AM	Biotech ETFs trade higher on upbeat coronavirus results (MarketWatch)
Dec-23-19 12:00PM	Will Biotech ETFs Excel in Election Year Post a Surge in 2019? (Zacks)
Dec-18-19 01:41PM	Best & Worst Monthly Performers: December 18 Edition (ETF Database)
Nov-25-19 06:55PM	Genomics ETFs Surge on CRISPR's Gene Editing Progress (Zacks)
Nov-21-19 12:56PM	Best & Worst Monthly Performers: November 21 Edition (ETF Database)
Nov-04-19 01:00PM	Value Biotech ETFs & Stocks to Buy Now (Zacks)
Oct-23-19 10:10AM	Biotech ETFs Surge on a Flurry of Positive News (Zacks)
Sep-06-19 03:07PM	ETFs Poised to Benefit from Gene Editing Revolution (Zacks)
Sep-04-19 03:18PM	ETFs to Gain From the Booming Genomics Market (Zacks)

iShares Genomics Immunology and Healthcare ETF seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

open in yahoo | open in marketwatch | open in google

Black Swan Sale

50% Off Elite

iShares Genomics Immunology and Healthcare ETF

Upgrade your FINVIZ experience